A Randomized Phase I/II Study to Assess the Safety, Tolerability, and Efficacy of GMI-1271 in Patients With Calf-Level Deep Venous Thrombosis
Status: Terminated
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
This study will evaluate the safety profile of GMI-1271 and its effect on thrombus resolution in patients with distal calf vein Deep Venous Thrombosis (DVT).
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:
• Age 18-75 years
• Male or female
• Diagnosed with acute isolated calf vein Deep Venous Thrombosis (DVT)
• Willing and able to participate in all required evaluations and procedures in this study protocol
Locations
United States
Michigan
University of Michigan
Ann Arbor
Time Frame
Start Date: 2016-07
Completion Date: 2016-11
Participants
Target number of participants: 2
Treatments
Experimental: GMI-1271
Active_comparator: Enoxaparin Sodium (Lovenox®)
Authors
Related Therapeutic Areas
Sponsors
Collaborators: University of Michigan
Leads: GlycoMimetics Incorporated